An industry funded study concludes the branded palmitoylethanolamide (PEA) ingredient ‘Levagen+’ is safe and effective in reducing the incidence and symptoms associated with upper respiratory tract infections (URTIs).
An industry funded study concludes the branded palmitoylethanolamide (PEA) ingredient ‘Levagen+’ is safe and effective in reducing the incidence and symptoms associated with upper respiratory tract infections (URTIs).
Over the past few years, CBD has painted an elaborate picture of wonder and excitement, but science has created a new reality centered around PEA, a CBD alternative.